Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer

Abstract

⁶⁸Ga-FAPI PET/CT as an examination modality is excellent for evaluation of newly diagnosed NSCLC. ⁶⁸Ga-FAPI PET/CT improves the detection rates of most metastases and facilitating the superior staging of patients with newly diagnosed NSCLC, relative to that achieved by ¹⁸F-FDG PET/CT.